We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+6.52%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$15.2B
AUM Growth
-$714M
Cap. Flow
-$1.36B
Cap. Flow %
-8.94%
Top 10 Hldgs %
15.97%
Holding
2,218
New
180
Increased
888
Reduced
1,035
Closed
85
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCLH icon
1226
Norwegian Cruise Line
NCLH
$8.84B
$1.37M 0.01%
49,807
+9,392
+23% +$250K
INO icon
1227
Inovio Pharmaceuticals
INO
$69M
$1.37M 0.01%
12,329
-514
-4% -$67.6K
EGOV
1228
DELISTED
NIC Inc
EGOV
$1.37M 0.01%
40,392
+32,056
+385% +$1.01M
PFN
1229
PIMCO Income Strategy Fund II
PFN
$703M
$1.36M 0.01%
132,830
+21,124
+19% +$215K
DBL
1230
DoubleLine Opportunistic Credit Fund
DBL
$280M
$1.36M 0.01%
68,996
+15,091
+28% +$298K
LECO icon
1231
Lincoln Electric
LECO
$15.4B
$1.36M 0.01%
11,074
-1,997
-15% -$239K
ORAN
1232
DELISTED
Orange
ORAN
$1.36M 0.01%
110,373
+16,342
+17% +$197K
EQT icon
1233
EQT Corp
EQT
$32.3B
$1.36M 0.01%
73,194
+38,307
+110% +$667K
GMAB icon
1234
Genmab
GMAB
$19.5B
$1.36M 0.01%
41,407
+13,662
+49% +$514K
NTST
1235
NETSTREIT Corp
NTST
$2.1B
$1.36M 0.01%
73,494
-76,378
-51% -$1.36M
BAH icon
1236
Booz Allen Hamilton
BAH
$9.15B
$1.36M 0.01%
16,842
-14,913
-47% -$1.25M
MED icon
1237
Medifast
MED
$141M
$1.35M 0.01%
6,381
-4,044
-39% -$968K
PDT
1238
John Hancock Premium Dividend Fund
PDT
$626M
$1.35M 0.01%
90,437
+31,379
+53% +$441K
SVM
1239
Silvercorp Metals
SVM
$2.53B
$1.35M 0.01%
274,989
-10,200
-4% -$59.8K
LITE icon
1240
Lumentum
LITE
$69.3B
$1.35M 0.01%
14,760
-2,596
-15% -$240K
PB icon
1241
Prosperity Bancshares
PB
$8.89B
$1.34M 0.01%
17,956
+7,188
+67% +$526K
AGCO icon
1242
AGCO
AGCO
$7.2B
$1.34M 0.01%
9,360
-7,329
-44% -$914K
AJRD
1243
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$1.34M 0.01%
28,595
-121,737
-81% -$6.19M
RP
1244
DELISTED
RealPage, Inc.
RP
$1.34M 0.01%
15,370
+2,933
+24% +$255K
APA icon
1245
APA Corp
APA
$13.2B
$1.34M 0.01%
74,868
+2,113
+3% +$38.6K
BLUE
1246
DELISTED
bluebird bio
BLUE
$1.34M 0.01%
3,423
+261
+8% +$129K
KNSL icon
1247
Kinsale Capital Group
KNSL
$8.51B
$1.33M 0.01%
8,094
-1,330
-14% -$244K
CCOI icon
1248
Cogent Communications
CCOI
$508M
$1.33M 0.01%
19,327
-5,543
-22% -$339K
OPLN
1249
Openlane
OPLN
$4.54B
$1.33M 0.01%
88,616
-18,739
-17% -$319K
TCBK icon
1250
TriCo Bancshares
TCBK
$1.83B
$1.33M 0.01%
28,022
+3,563
+15% +$154K

Similar funds

Guggenheim Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Guggenheim Capital held 2,218 positions worth $15.2B, down 4.5% from $15.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Guggenheim Capital withdrew a net $1.36B in Q1 2021, closing 85 positions and reducing 1,035 holdings. Its most notable exit was Gores Holdings VI, Inc. Unit, an estimated $42.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant worth $153M.

  • Guggenheim Capital's largest Q1 2021 buy was KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant: 15,276,972 shares worth $153M.
  • Guggenheim Capital added most to Pioneer Natural Resource Co. in Q1 2021, an estimated $19.4M increase.
  • Guggenheim Capital's biggest Q1 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.08B.
  • Guggenheim Capital fully exited Gores Holdings VI, Inc. Unit in Q1 2021, selling an estimated $42.4M.
  • Guggenheim Capital's ten largest holdings make up 16% of its $15.2B portfolio in Q1 2021.
  • Guggenheim Capital opened 180 new positions and closed 85 in Q1 2021.
  • Guggenheim Capital's portfolio value fell 4.5% quarter-over-quarter to $15.2B.

Based on Guggenheim Capital's 13F filing for Q1 2021, filed 13 May 2021.